DSNKY:OTCMKTS
Daiichi Sankyo Co Ltd - ADR
$19.00
0.00%
(0.00) 1D
$19.00
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 22, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSNKY...
Open
$19.74
High
$19.74
Low
$18.41
Mkt. cap
35.28B
Avg. vol.
94.88K
Volume
61.40K
Dividend
2.58%
Quarterly dividend
$0.12
P/E ratio
22.58
52-wk high
$27.50
52-wk low
$14.98
EPS
$0.84
Beta
0.12
Shares outstanding
1.86B
No. of employees
20K
Open
$19.74
High
$19.74
Low
$18.41
Mkt. cap
35.28B
Avg. vol.
94.88K
Volume
61.40K
Dividend
2.58%
Quarterly dividend
$0.12
P/E ratio
22.58
52-wk high
$27.50
52-wk low
$14.98
EPS
$0.84
Beta
0.12
Shares outstanding
1.86B
No. of employees
20K
News stories
From web sources and news partners
Investing.com
·
2 days ago
Enhertu receives EU committee backing for early breast cancer
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd - ADR
CEOHiroyuki Okuzawa
Employees20.2K
FoundedSep 28, 2005
HeadquartersChuo City, Tokyo, Japan
Sector-
Websitedaiichisankyo.co.jp